toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
Details
   print

Deprecated: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in /home/acutrialsocom/public_html/refbase-ocom/includes/include.inc.php on line 5275
  Record Links
Author (up) Anastasi, J. K.; McMahon, D. J.; Kim, G. H. url  openurl
  Title Symptom management for irritable bowel syndrome: a pilot randomized controlled trial of acupuncture/moxibustion Type of Study RCT
  Year 2009 Publication Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates. Abbreviated Journal Gastroenterol Nurs  
  Volume 32 Issue 4 Pages 243-255 JA - Gastroente  
  Keywords Acu Versus Sham; Acupuncture; AcuTrials; Gastrointestinal Diseases; Individualized Acupuncture Protocol; Penetrating Sham; Irritable Bowel Syndrome; Moxibustion; Near Verum Acupoint Control; Pilot Study; RCT; Restricted Modalities, Acupuncture + Other; Superficial Needling Depth; Sham Control; Sham Moxa; TCM Acupuncture Style; Traditional Diagnosis Based Point Selection; IBS  
  Abstract The purpose of this pilot study was to assess the effect of an individualized traditional Chinese medicine (TCM) acupuncture and moxibustion (Acu/Moxa) treatment on symptom control in patients with irritable bowel syndrome (IBS) in a preliminary, randomized, sham/placebo-controlled trial. Twenty-nine men and women with IBS were randomized to either individualized Acu/Moxa (treatment group) or sham/placebo Acu/Moxa (control group). All subjects were assessed by a diagnostic acupuncturist for a TCM evaluation and individualized point prescription. Only those subjects assigned to the experimental group received the individually prescribed treatment. The diagnostic acupuncturist did not administer treatments and was blind to treatment assignments. All subjects kept a symptom diary for the duration of the study, enabling measurement of symptom frequency, severity, and improvement. The Clinical Global Impression Scale was administered preintervention to establish baseline severity and on completion of the 4-week, eight-session treatment intervention. After 4 weeks of twice-weekly Acu/Moxa treatment, average daily abdominal pain/discomfort improved whereas the control group showed minimal reduction. This between-group difference adjusted for baseline difference was statistically significant. The intestinal gas, bloating, and stool consistency composite score showed a similar pattern of improvement. The findings indicate that Acu/Moxa treatment shows promise in the area of symptom management for IBS  
  Address Columbia University School of Nursing, New York, NY 10032, USA. jka8@columbia.edu  
  Publisher
  Language Number of Treatments 8  
  Treatment Follow-up N/A Frequency >1/WK Number of Participants 29  
  Time in Treatment 4 Weeks Condition Irritable Bowel Syndrome
  Disease Category Gastrointestinal Diseases OCSI Score  
  Notes Approved no  
  Call Number Serial 27  
Permanent link to this record
Select All    Deselect All
 |   | 
Details
   print

Save Citations:
Export Records: